| 英文名称 |
中文名称 |
CAS号 |
操作 |
| TW37 |
N-[4-(2-叔丁基苯磺酰基)苯基]-2,3,4-三羟基-5-(2-异丙基苯基甲基)苯甲酰胺 |
877877-35-5 |
详细
|
| LDC-1267 |
LDC1267 |
1361030-48-9 |
详细
|
| CC115 |
CC-115 |
1228013-15-7 |
详细
|
| LJH-685 |
2,6-二氟-4-[4-[4-(4-甲基-1-哌嗪基)苯基]-3-吡啶基]苯酚 |
1627710-50-2 |
详细
|
| Selonsertib |
SELONSERTIB |
1448428-04-3 |
详细
|
| BFH-772 |
CS-2412 |
890128-81-1 |
详细
|
| AZ960 |
5-氟-2-[[(1S)-1-(4-氟苯基)乙基]氨基]-6-[(5-甲基-1H-吡唑-3-基)氨基]-3-吡啶腈 |
905586-69-8 |
详细
|
| ENMD2076 |
6-(4-甲基-1-哌嗪基)-N-(5-甲基-1H-吡唑-3-基)-2-[(1E)-2-苯乙烯基]-4-嘧啶胺 |
934353-76-1 |
详细
|
| VER-49009 |
VER-49009 |
940289-57-6 |
详细
|
| LY-2874455 |
LY2874455 |
1254473-64-7 |
详细
|
| Selinexor (KPT-330) |
塞利尼索 |
1393477-72-9 |
详细
|
| DEBIO-1347;CH-5183284 |
DEBIO-1347 |
1265229-25-1 |
详细
|
| FIIN2 |
FIIN-2 |
1633044-56-0 |
详细
|
| Basic Fuchsin |
副品红；盐酸副品红 |
569-61-9 |
详细
|
| ABT263 (Navitoclax) |
ABT 263 |
923564-51-6 |
详细
|
| S3I-201 |
S3I-201 |
501919-59-1 |
详细
|
| Bikinin |
Bikinin |
188011-69-0 |
详细
|
| Rociletinib (CO-1686, AVL-301) |
CO1686 |
1374640-70-6 |
详细
|
| NVP-CGM-097 |
CS-1248 |
1313363-54-0 |
详细
|
| IM12 |
IM-12 |
1129669-05-1 |
详细
|
| WIKI4 |
化合物WIKI4 |
838818-26-1 |
详细
|
| Pexidartinib (PLX-3397) |
培西达替尼 |
1029044-16-3 |
详细
|
| AZD-0156 |
AZD0156 |
1821428-35-6 |
详细
|
| NSC12,NSC 172285 |
CS-2161 |
102586-30-1 |
详细
|
| α-Methyl-L-tyrosine |
甲酪氨酸；α-甲基-L-酪氨酸 |
672-87-7 |
详细
|
| TSU68 (SU6668, Orantinib) |
orantinib |
252916-29-3 |
详细
|
| Tenovin6 |
TENOVIN-6 |
1011557-82-6 |
详细
|
| VER50589 |
VER-50589 |
747413-08-7 |
详细
|
| AZ-20 |
AZ20 |
1233339-22-4 |
详细
|
| XL-019 |
XL019 |
945755-56-6 |
详细
|
| GDC0152 |
GDC-0152 |
873652-48-3 |
详细
|
| AZD-3463 |
AZD3463 |
1356962-20-3 |
详细
|
| Idasanutlin (RG-7388) |
RG 7388 |
1229705-06-9 |
详细
|
| Radotinib(IY-5511) |
拉多替尼 |
926037-48-1 |
详细
|
| AMG-925 |
AMG-925 |
1401033-86-0 |
详细
|
| AZD-8186 |
8-[(1R)-1-[(3,5-二氟苯基)氨基]乙基]-N,N-二甲基-2-(4-吗啉基)-4-氧代-4H-1-苯并吡喃-6-甲酰胺 |
1627494-13-6 |
详细
|
| LJI-308 |
LJI308 |
1627709-94-7 |
详细
|
| BDA366 |
1-[[(2S)-3-(二乙基氨基)-2-羟基丙基]氨基]-4-[[(2S)-2-环氧乙烷基甲基]氨基]-9,10-蒽醌 |
1909226-00-1 |
详细
|
| SKL-2001 |
SKL2001 |
909089-13-0 |
详细
|
| NQDI 1 |
NQDI 1 |
175026-96-7 |
详细
|
| GNF-7 |
GNF-7 |
839706-07-9 |
详细
|
| Q-VD-Oph |
(3S)-5-(2,6-二氟苯氧基)-3-[[(2S)-3-甲基-1-氧代-2-[(2-喹啉甲酰基)氨基]丁基]氨基]-4-氧代-戊酸 |
1135695-98-5 |
详细
|
| VX970;VE822 |
Berzosertib(VE-822) |
1232416-25-9 |
详细
|
| BLZ-945 |
BLZ945 |
953769-46-5 |
详细
|
| JNJ-42756493 (Erdafitinib) |
厄达替尼 |
1346242-81-6 |
详细
|
| Epacadostat (INCB-024360) |
艾卡哚司他 |
1204669-58-8 |
详细
|
| MX69 |
MX69 |
1005264-47-0 |
详细
|
| ThiametG |
THIAMET G |
1009816-48-1 |
详细
|
| APR246 (PRIMA-1MET) |
APR-246 |
5291-32-7 |
详细
|
| BMS911543 |
BMS-911543 |
1271022-90-2 |
详细
|
| Filgotinib (GLPG0634) |
非戈替尼 |
1206161-97-8 |
详细
|
| AZD-2932 |
AZD2932 |
883986-34-3 |
详细
|
| PF-03394197 |
奥拉替尼 |
1208319-26-9 |
详细
|
| UNC-2881 |
UNC2881 |
1493764-08-1 |
详细
|
| UMI77 |
UMI-77 |
518303-20-3 |
详细
|
| LY-2584702 (tosylate salt) |
LY2584702 TOSYLATE |
1082949-68-5 |
详细
|
| 7,8-Dihydroxyflavone |
7，8-DHF；7，8-二羟基黄酮 |
38183-03-8 |
详细
|
| Tyrphostin, AGS 200 |
AG1024 |
65678-07-1 |
详细
|
| RG7112 (RO5045337) |
[(4R,5S)-4,5-双(4-氯苯基)-2-[4-(1,1-二甲基乙基)-2-乙氧基苯基]-4,5-二氢-4,5-二甲基-1H-咪唑-1-基][4-[3-(甲磺酰基)丙基]-1-哌嗪基]甲酮 |
939981-39-2 |
详细
|
| ICG-001 |
ICG-001 |
847591-62-2 |
详细
|
| FH 535 |
2,5-二氯-N-(2-甲基-4-硝基苯基)苯磺酰胺 |
108409-83-2 |
详细
|
| ASP-3026 |
ASP3026 |
1097917-15-1 |
详细
|
| GSK-2606414 |
GSK2606414 |
1337531-36-8 |
详细
|
| BAM-7 |
BAM7 |
331244-89-4 |
详细
|
| LCL161 |
LCL161 |
1005342-46-0 |
详细
|
| GSK-2656157 |
GSK2656157 |
1337532-29-2 |
详细
|
| GNF5837 |
GNF 5837 |
1033769-28-6 |
详细
|
| G749 |
G-749 |
1457983-28-6 |
详细
|
| CX6258 HCl |
CX-6258HCL |
1353859-00-3 |
详细
|
| ANA12 |
ANA-12 |
219766-25-3 |
详细
|
| TP0903 |
TP-0903 |
1341200-45-0 |
详细
|
| Tasisulam,LY573636 |
他斯索兰 |
519055-62-0 |
详细
|
| PDGFR740Y-P |
1236188-16-1 |
1236188-16-1 |
详细
|
| VX-765,VX 765 |
N-(4-氨基-3-氯苯甲酰基)-3-甲基-L-缬氨酰-N-[(2R,3S)-2-乙氧基四氢-5-氧代-3-呋喃基]-L-脯氨酰胺 |
273404-37-8 |
详细
|
| ISRIB(trans-isomer) |
ISRIB(TRANS-ISOMER) 抑制剂 |
1597403-47-8 |
详细
|
| A1210477 |
A-1210477 |
1668553-26-1 |
详细
|
| Embelin;NSC91874 |
恩贝酸 |
550-24-3 |
详细
|
| Go6983 |
3-[1-[3-(二甲基氨基)丙基]-5-甲氧基-1H-吲哚-3-基]-4-(1H-吲哚-3-基)-1H-吡咯-2,5-二酮 |
133053-19-7 |
详细
|
| Degrasyn (WP-1130) |
WP1130 |
856243-80-6 |
详细
|
| Pacritinib;SB-1518 |
帕克替尼 |
937272-79-2 |
详细
|
| SSR128129E |
SSR128129E |
848318-25-2 |
详细
|
| UNC-2250 |
反式-4-[[2-(丁基氨基)-5-[5-(4-吗啉基甲基)-2-吡啶基]-4-嘧啶基]氨基]环己醇 |
1493694-70-4 |
详细
|
| YH239-EE |
YH239-EE，YH239乙酯 |
1364488-67-4 |
详细
|
| Mirin |
(5Z)-2-氨基-5-[(4-羟基苯基)亚甲基]-4(5H)-噻唑酮 |
1198097-97-0 |
详细
|
| Olmutinib (HM61713, BI1482694) |
奥莫替尼 |
1353550-13-6 |
详细
|
| PF-03394197;Oclacitinib maleate |
PF-03394197 |
1640292-55-2 |
详细
|
| CZ-415 |
CZ415 |
1429639-50-8 |
详细
|
| KYA1797K |
CS-2581 |
1956356-56-1 |
详细
|
| BIO-acetoxime |
6-溴靛玉红-3'-丙酮肟 |
667463-85-6 |
详细
|
| AEB071 |
3-(1H-吲哚-3-基)-4-[2-(4-甲基哌嗪-1-基)喹唑啉-4-基]吡咯-2,5-二酮 |
425637-18-9 |
详细
|
| NSC-348884 |
N1,N1,N2,N2-四[(6-甲基-1H-苯并咪唑-2-基)甲基]-1,2-乙二胺 |
81624-55-7 |
详细
|
| AT-406 (SM-406, ARRY-334543) |
AT-406 |
1071992-99-8 |
详细
|
| XMD8-87 |
5,11-二氢-2-((2-甲氧基-4-(4-甲基-1-哌嗪基)苯基)氨基)-11-甲基-6H-嘧啶并[4,5-B][1,4]苯并二氮杂卓-6-酮 |
1234480-46-6 |
详细
|
| SH-4-54 |
SH-4-54 |
1456632-40-8 |
详细
|
| MHY 1485 |
MHY1485 |
326914-06-1 |
详细
|
| Z-IETD-FMK |
CASPASE-8抑制剂 |
210344-98-2 |
详细
|
| RXDX-101 |
Entrectinib;恩曲替尼 |
1108743-60-7 |
详细
|
| NSC-59984 |
1-(4-甲基-1-哌嗪基)-3-(5-硝基-2-呋喃基)-2-丙烯-1-酮 |
803647-40-7 |
详细
|
| BAW2881 |
BAW2881 |
861875-60-7 |
详细
|
| XMD16-5 |
2-((4-(4-羟基哌啶-1-基)苯基)氨基)-11-甲基-5H-苯并[E]嘧啶并[5,4-B][1,4]二氮杂卓-6(11H)-酮 |
1345098-78-3 |
详细
|